Market overview
The global remote patient monitoring market is worth USD 25.7 bn in 2026 and is forecast to reach USD 114 bn by 2036, growing at a 16.0% CAGR. United States is the largest country market and Monitoring services is the largest by component segment.
| Scope | Devices, software platforms and monitoring services that track patients' health data at home and transmit it to clinicians, covering blood pressure, glucose, weight, oxygen, cardiac and activity monitoring. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 22.0 bn |
| Value 2026 | USD 25.7 bn |
| Value 2036 | USD 114 bn |
| CAGR 2026-2036 | 16.0% |
| Volume 2026 | 46.6 million patients |
| Volume 2036 | 195 million patients |
| Average price 2026 | USD 553 per patient |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Remote Patient Monitoring market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 25.7 bn |
| 2027 | USD 29.9 bn |
| 2028 | USD 34.6 bn |
| 2029 | USD 40.2 bn |
| 2030 | USD 46.6 bn |
| 2031 | USD 54.1 bn |
| 2032 | USD 62.7 bn |
| 2033 | USD 72.7 bn |
| 2034 | USD 84.4 bn |
| 2035 | USD 97.9 bn |
| 2036 | USD 114 bn |
Remote Patient Monitoring market segmentation
By component
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Devices | 34.0% | 25.9% | USD 8.8 bn | 12.9% |
| Software platforms | 30.0% | 35.2% | USD 7.7 bn | 17.9% |
| Monitoring services | 36.0% | 38.8% | USD 9.3 bn | 16.9% |
By condition
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Cardiovascular | 34.0% | 30.0% | USD 8.8 bn | 14.6% |
| Diabetes | 24.0% | 21.2% | USD 6.2 bn | 14.6% |
| Respiratory | 12.0% | 11.5% | USD 3.1 bn | 15.6% |
| Maternal and other | 30.0% | 37.3% | USD 7.7 bn | 18.5% |
By end user
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Home care | 42.0% | 48.0% | USD 10.8 bn | 17.6% |
| Hospitals | 30.0% | 26.0% | USD 7.7 bn | 14.3% |
| Ambulatory and clinics | 20.0% | 18.0% | USD 5.1 bn | 14.8% |
| Payers and employers | 8.0% | 8.0% | USD 2.1 bn | 16.0% |
By measure
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Vital signs | 34.0% | 30.0% | USD 8.8 bn | 14.6% |
| Glucose | 20.0% | 20.0% | USD 5.1 bn | 16.0% |
| Cardiac rhythm and blood pressure | 26.0% | 26.0% | USD 6.7 bn | 16.0% |
| Respiratory and other | 20.0% | 24.0% | USD 5.1 bn | 18.1% |
By connectivity
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Bluetooth and Wi-Fi | 50.0% | 46.0% | USD 12.9 bn | 15.0% |
| Cellular | 34.0% | 38.0% | USD 8.8 bn | 17.3% |
| Wired and other | 16.0% | 16.0% | USD 4.1 bn | 16.0% |
Top 25 countries for remote patient monitoring by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 91.0% of 2026 revenue and the 25 countries below together hold 97.5%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 12.9 bn | 50.0% | USD 52.0 bn | 15.0% |
| 2 | China | USD 2.6 bn | 10.0% | USD 15.9 bn | 20.0% |
| 3 | Germany | USD 1.5 bn | 6.0% | USD 6.2 bn | 15.0% |
| 4 | United Kingdom | USD 1.3 bn | 5.0% | USD 5.7 bn | 16.0% |
| 5 | Japan | USD 1.3 bn | 5.0% | USD 4.8 bn | 14.0% |
| 6 | France | USD 1.0 bn | 4.0% | USD 4.2 bn | 15.1% |
| 7 | India | USD 772 mn | 3.0% | USD 6.1 bn | 23.0% |
| 8 | Canada | USD 772 mn | 3.0% | USD 3.1 bn | 14.8% |
| 9 | Australia | USD 644 mn | 2.5% | USD 2.8 bn | 16.0% |
| 10 | Italy | USD 644 mn | 2.5% | USD 2.6 bn | 15.0% |
| 11 | Netherlands | USD 371 mn | 1.4% | USD 1.5 bn | 15.0% |
| 12 | Switzerland | USD 221 mn | 0.9% | USD 897 mn | 15.0% |
| 13 | Spain | USD 162 mn | 0.6% | USD 659 mn | 15.0% |
| 14 | Mexico | USD 131 mn | 0.5% | USD 749 mn | 19.0% |
| 15 | South Korea | USD 111 mn | 0.4% | USD 454 mn | 15.2% |
| 16 | Sweden | USD 98 mn | 0.4% | USD 386 mn | 14.7% |
| 17 | Singapore | USD 85 mn | 0.3% | USD 500 mn | 19.4% |
| 18 | Brazil | USD 77 mn | 0.3% | USD 443 mn | 19.1% |
| 19 | Russia | USD 72 mn | 0.3% | USD 284 mn | 14.7% |
| 20 | Saudi Arabia | USD 67 mn | 0.3% | USD 375 mn | 18.8% |
| 21 | Israel | USD 62 mn | 0.2% | USD 352 mn | 19.0% |
| 22 | Turkey | USD 57 mn | 0.2% | USD 329 mn | 19.2% |
| 23 | Denmark | USD 54 mn | 0.2% | USD 216 mn | 14.8% |
| 24 | Taiwan | USD 51 mn | 0.2% | USD 204 mn | 14.8% |
| 25 | Belgium | USD 49 mn | 0.2% | USD 193 mn | 14.7% |
| Rest of world | USD 649 mn | 2.5% | USD 2.6 bn | 14.7% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Philips
- Medtronic
- Omron Healthcare
- Masimo
- GE HealthCare
- iRhythm Technologies
- Abbott
Group 2: Regional and specialist players
- Dexcom
- Biotricity
- BioIntelliSense
- Health Recovery Solutions
- Withings
- Validic
- Cadence
Group 3: Emerging and niche players
- Vivify Health
- Doccla
- Docobo
- Datos Health
- Spry Health
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the remote patient monitoring market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 16.0% is calculated from the resulting values.
The market is divided by component, by condition, by end user, by measure, by connectivity. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the remote patient monitoring market?
The global remote patient monitoring market is estimated at USD 22.0 bn in 2025 and USD 25.7 bn in 2026.
How fast will the remote patient monitoring market grow?
It is forecast to reach USD 114 bn by 2036, a compound annual growth rate of 16.0% from 2026, an increase of USD 87.8 bn.
Which country is the largest market for remote patient monitoring?
United States is the largest market by revenue at USD 12.9 bn in 2026, 50.0% of the global total. The three largest countries together hold 66.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 23.0% a year from 2026 to 2036.
Which remote patient monitoring segment is largest?
In the by component split, Monitoring services is the largest segment with 36.0% of 2026 revenue.
Who are the leading remote patient monitoring companies?
Global leaders include Philips, Medtronic, Omron Healthcare, Masimo.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Drug Discovery ServicesUSD 26.4 bn · 10.5% CAGR
- Wound CareUSD 26.5 bn · 6.0% CAGR
- Cell CultureUSD 23.9 bn · 8.0% CAGR
- Oral Drug DeliveryUSD 22.6 bn · 7.5% CAGR
- Ocular Drug DeliveryUSD 29.7 bn · 6.0% CAGR
- Biopharmaceutical LogisticsUSD 21.7 bn · 9.0% CAGR
- Pharmaceutical Cold ChainUSD 21.6 bn · 8.0% CAGR
- SyringeUSD 21.2 bn · 6.5% CAGR